ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells.
Shou-Sen HuangChung-Hsin TsaiChi-Yu KuoYing-Syuan LiShih-Ping ChengPublished in: Endocrine (2022)
Targeting ACLY holds the potential for being a novel therapeutic strategy for thyroid cancer.